EGFR tyrosine kinase inhibitory peptide attenuates Helicobacter pylori-mediated hyper-proliferation in AGS enteric epithelial cells

Toxicology and Applied Pharmacology

Volumn 269, Issue 3, 2013, Pages 205-214

  Himaya, S W A ^a   Dewapriya, Pradeep ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Catenin; EGFR; Gastric epithelial cells; Helicobacter pylori; Peptide

Indexed keywords

BACTERIAL PROTEIN; BETA CATENIN; CYCLIN D; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; MATRILYSIN; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN HYDROLYSATE; PROTEIN KINASE B;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HELICOBACTER; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH EPITHELIUM; UPREGULATION;

BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CHLAMYDOMONAS; EPITHELIUM; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICROSCOPY, ELECTRON, SCANNING; OLIGOPEPTIDES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; STOMACH NEOPLASMS;

CHLAMYDOMONAS; HELICOBACTER PYLORI;

EID: 84876971455     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.03.020     Document Type: Article

References (39)

1. Becker E.W. Micro-algae as a source of protein. Biotechnol. Adv. 2007, 25:207-210.
2. Bikadi Z., Hazai E. Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J. Chem. Inf. Model. 2009, 1:15.
3. Cardó-Vila M., Giordano R.J., Sidman R.L., Bronk L.F., Fan Z., Mendelsohn J., Arap W., Pasqualini R. From combinatorial peptide selection to drug prototype (II): targeting the epidermal growth factor receptor pathway. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5118-5123.
4. Castillo-Juarez I., Rivero-Cruz F., Celis H., Romero I. Anti-Helicobacter pylori activity of anacardic acids from Amphipterygium adstingens. J. Ethnopharmacol. 2007, 114:72-77.
5. Coyle W.J., Sedlack R.E., Nemec R. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor. Am. J. Gastroenterol. 1999, 94:2885-2889.
6. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
7. de Boer W., Tytgat N.J.G. Regular review: treatment of Helicobacter pylori infection. Br. Med. J. 2000, 320:31-34.
8. Emami J. In vitro-in vivo correlation: from theory to applications. J. Pharm. Pharm. Sci. 2006, 9:169-189.
9. Franke T.F., Kaplan D.R., Cantley L.C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 1997, 275:665-668.
10. Fraser A.G., Sim R., Sankey E.A., Dhillon A.P., Pounder R.E. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment. Pharmacol. Ther. 1994, 8:167-173.
11. Geethangili M., Fang S.H., Lai C.H., Rao Y.K., Lien H.M., Tzeng Y.M. Inhibitory effect of Antrodia camphorate constituents on the Helicobacter pylori-associated gastric inflammation. Food Chem. 2010, 119:149-153.
12. Halgren T.A. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 1998, 17:490-519.
13. Hatti K.S., Chandregowada V., Rao G.V., Kush A., Reddy G.C. In silico interaction studies of quinazoline derivatives for their inhibitory action on both wild and mutant EGFRs. J. Proteomics Bioinform. 2009, 2:126-130.
14. Hirao T., Sawada H., Koyama F. Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer. Cancer Gene Ther. 1999, 6:423-427.
15. Kang K.H., Qian Z.J., Ryu B. Protective effects of protein hydrolysate from marine microalgae Navicula incerta onethanol-inducedtoxicityinHepG2/CYP2E1cells. Food Chem. 2012, 132:677-685.
16. Keates S., Keates A.C., Katcher K., Peek R.M., Kelly C.P. Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J. Infect. Dis. 2007, 196:95-103.
17. Kuniyasu H., Yasui W., Yokozaki H., Tahara E. Helicobacter pylori infection and carcinogenesis of the stomach. Langenbecks Arch. Surg. 2000, 385:69-74.
18. Kurashima Y., Murata-Kamiya N., Kikuchi K., Higashi H., Azuma T., Kondo S., Hatakeyama M. Deregulation of beta-catenin signal by Helicobacter pylori CagA requires the CagA-multimerization sequence. Int. J. Cancer 2008, 122:823-831.
19. Lai C.H., Kuo C.H., Chen P.Y., Poon S.K., Chang C.S., Wang W.C. Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates. J. Antimicrob. Chemother. 2006, 57:466-471.
20. Lee D.H., Szczepanski M.J., Yong J.L. Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J. Cell. Biochem. 2009, 106:1113-1122.
21. Maeda S., Yoshida H., Mitsuno Y. Analysis of apoptotic and anti-apoptotic signaling pathways induced by Helicobacter pylori. Mol. Pathol. 2002, 55:286-293.
22. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., Oslon A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 1998, 19:1639-1662.
23. Nagy T.A., Frey M.R., Yan F., Israel D.A., Polk D.B., Peek R.M. Helicobacter pylori regulate migration and apoptosis by activation of PI3K signaling. J. Infect. Dis. 2009, 199:641-651.
24. Nakayama M., Hisatsune J., Yamasaki E., Isomoto H., Kurazono H., Hatakeyama M., Azuma T., Yamaoka Y., Yahiro K., Moss J., Hirayama T. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J. Biol. Chem. 2009, 284:1612-1619.
25. Naumann M., Crabtree J.E. Helicobacter pylori-induced epithelial cell signaling in gastric carcinogenesis. Trends Microbiol. 2004, 12:29-36.
26. Normanno N., De Luca A., Bianco C. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366:2-16.
27. Peek R.M., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2002, 2:28-37.
28. Peek R.M., Crabtree J.E. Helicobacter infection and gastric neoplasia. J. Pathol. 2006, 208:233-248.
29. Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Nat. Rev. Cancer 2010, 10:403-414.
30. Rao Y.K., Lien H.M., Lin Y.H., Hsu Y.M., Yeh C.T., Chen C.C., Lai C.H., Tzeng Y.M. Antibacterial activities of Anisomeles indica constituents and their inhibition effect on Helicobacter pylori induced inflammation in human gastric epithelial cells. Food Chem. 2012, 132:780-787.
31. Ryu B., Kang K.H., Ngo D.H. Statistical optimization of microalgae Pavlova lutheri cultivation conditions and its fermentation conditions by yeast, Candida rugopelliculosa. Bioresour. Technol. 2012, 107:307-313.
32. Solis F.J., Wets R.J.B. Minimization by random search techniques. Math. Oper. Res. 1981, 6:19-30.
33. Tolwinski N.S., Wieschaus E. Rethinking WNT signalling. Trends Genet. 2004, 20:177-181.
34. Wild C.P. The role of cancer research in noncommunicable disease control. J. Natl. Cancer Inst. 2012, 104:1051-1058.
35. Wong B.C., Wang W.P., So W.H. Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 2001, 15:1459-1465.
36. Wroblewski L.E., Peek R.M. Targeted disruption of the epithelial-barrier by Helicobacter pylori. Cell Commun. Signal 2011, 9:29.
37. Wroblewski L.E., Peek R.M., Wilson K.T. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 2010, 23:713-739.
38. Wu S., Morin P.J., Maouyo D., Sears C.L. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 2003, 124:392-400.
39. Yasuda H., Kobayashi S., Costa D.B. EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications. Lancet Oncol. 2012, 13:23-31.